Epilepsygtx Limited
- Company number
- 13415161
- Status
- Active
- Type
- Ltd
- Incorporated
- 24 May 2021
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- GMV Nominees Ltd (48216 companies)
Registered office
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dimitri Michael Kullmann | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
24 May 2021 | 9 May 2022 |
| Ucl Business Ltd | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
9 May 2022 | 2 Aug 2022 |
| Albion Capital Group Llp | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
9 May 2022 | 23 May 2023 |
| Utf General Partner 2 Llp | Right To Appoint And Remove Directors | 10 Feb 2025 | |
| Ucl Business Ltd | Right To Appoint And Remove Directors | 24 May 2022 |
Accounts
| Year ended | Cash | Employees |
|---|---|---|
| 31 Dec 2024 | - | - |
| 31 Dec 2023 | - | - |
| 31 Dec 2022 | - | - |
| 31 Dec 2021 | £26 | 0 |
Connections
Owned by
Epilepsygtx Limited → UCL Ventures Limited
Registered address
1,077 companies are registered at this address - likely a registration agent.